Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1165

1.

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

Pediatrics. 2003 Sep;112(3 Pt 1):559-64.

PMID:
12949284
2.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
3.

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

Diabet Med. 2006 Feb;23(2):141-7.

PMID:
16433711
4.
5.
7.

[Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].

Pańkowska E, Lipka M, Wysocka M, Szypowska A, Trippenbach-Dulska H, Czaplińska M, Kołodziejska B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(1):11-5. Polish.

PMID:
12831632
8.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
9.

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

Diabetes Care. 2005 Jul;28(7):1568-73.

PMID:
15983302
10.

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

Diabetes Care. 2003 Sep;26(9):2598-603.

PMID:
12941725
11.

Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

Pediatr Diabetes. 2008 Oct;9(5):472-9. doi: 10.1111/j.1399-5448.2008.00390.x. Epub 2008 Aug 20.

PMID:
18721168
12.

Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.

Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I.

Diabet Med. 2007 Dec;24(12):1419-23. Epub 2007 Oct 17.

PMID:
17941861
13.
14.

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

Diabetes Care. 2002 Nov;25(11):2074-80.

PMID:
12401759
15.
16.
17.

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.

Diabet Med. 2008 Mar;25(3):326-32. doi: 10.1111/j.1464-5491.2007.02365.x.

PMID:
18307459
18.

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

Diabetes Care. 2005 Mar;28(3):533-8.

PMID:
15735183
19.

Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

Diabetes Care. 2009 Jul;32(7):1170-6. doi: 10.2337/dc08-1874. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944.

20.
Items per page

Supplemental Content

Write to the Help Desk